Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 187.38
+18.70 (11.09%)
Jun 19, 2026, 3:30 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 16.25 billion as of June 18, 2026. Its market cap has increased by 238.74% in one year.
Market Cap
16.25B
Enterprise Value
12.03B
Revenue
6.41B
Ranking
n/a
PE Ratio
38.71
Stock Price
187.38
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 16.25B, an increase of 14,470.39%. That is a compound annual growth rate of 20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 16.25B | 125.85% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 62.72B |
| Innova Captab | 54.34B |
| Orchid Pharma | 49.66B |
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.13B |
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.88B |